Regarding the chemical class of CEACAM1 CEACAM2 CEACAM3 Inhibitors, these are theoretical compounds or agents that are conceived to interact with or modulate the activity of the CEACAM family of proteins. CEACAMs (Carcinoembryonic Antigen-related Cell Adhesion Molecules) are involved in various cellular processes, including cell adhesion, immune response modulation, and intracellular signaling.
The inhibitors for these proteins, in a general sense, can be designed to interfere with the protein-protein interactions, alter the signaling pathways in which these proteins are involved, or modulate the expression levels of these proteins. The inhibitors mentioned above, such as kinase inhibitors (e.g., Wortmannin, LY294002) and pathway-specific inhibitors (e.g., U0126 for MEK1/2), are examples of compounds that may indirectly influence CEACAM proteins by targeting the upstream or downstream components of the signaling pathways they are involved in. For instance, PI3K inhibitors might disrupt signaling cascades that regulate cell proliferation, survival, and metabolism, indirectly affecting CEACAM functions in these processes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $66.00 $219.00 $417.00 | 97 | |
Inhibits PI3K, a kinase involved in many signaling pathways, possibly affecting CEACAM mediated pathways. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
Another PI3K inhibitor, potentially alters signaling cascades that interact with CEACAM proteins. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
A p38 MAPK inhibitor, potentially modulating pathways linked to CEACAM function. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, possibly affecting signaling networks involving CEACAM proteins. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
An mTOR inhibitor, could alter cellular processes relevant to CEACAM signaling. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $92.00 $223.00 | 30 | |
Src family kinase inhibitor, might influence pathways interacting with CEACAMs. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
Inhibits Src kinases and Bcr-Abl, potentially impacting CEACAM associated pathways. | ||||||
BAY 11-7082 | 19542-67-7 | sc-200615B sc-200615 sc-200615A | 5 mg 10 mg 50 mg | $61.00 $83.00 $349.00 | 155 | |
NF-κB pathway inhibitor, might affect signaling relevant to CEACAM functions. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $39.00 $90.00 | 212 | |
MEK inhibitor, potentially alters MAPK/ERK pathway affecting CEACAM signaling. | ||||||
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
EGFR inhibitor, could modulate pathways that intersect with CEACAM related processes. | ||||||